A study at Rutgers University found the medications may be connected to a higher likelihood of ischemic optic neuropathy.

A new study found a small increase in the risk of a rare type of sudden vision loss among adults taking GLP-1 medications for ...

Use of GLP-1 RAs is associated with a higher risk for ischemic optic neuropathy compared with SGLT2is and DPP4is.

Three of the most widely prescribed semaglutide drugs, Ozempic, Rybelsus, and Wegovy, are now linked to reports of sudden ...

A study published in JAMA Ophthalmology has identified a potential link between popular weight-loss medications and severe, ...

Summary: Researchers unmasked a slight, statistically measurable increase in the risk of developing a rare, potentially permanent blinding condition known as ischemic optic neuropathy (a sudden ...

Please provide your email address to receive an email when new articles are posted on . A 42-year-old man with no significant medical history was urgently referred to New England Eye Center in July ...

As the use of GLP-1 receptor agonists continues to expand for diabetes and obesity treatment, clinicians are beginning to examine a possible new safety signal: rare cases of nonarteritic anterior ...

A large cohort study found that the use of GLP-1 receptor agonists (GLP-1 RAs) over 3 years was associated with a modestly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION) ...

A 24-year-old man developed progressive bilateral visual decline (left worse than right) after >1 year of non-medical oral exposure to a suspected tiletamine-containing product obtained online. He ...